ジバルプロエクスナトリウムの世界市場レポート 2025年

ジバルプロエクスナトリウム市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.2％で26億米ドルに成長します。予測期間中に予想される成長は、てんかん有病率の上昇、双極性障害の発生率の増加、片頭痛障害の診断率の上昇、神経疾患にかかりやすい高齢者人口の増加、ヘルスケアへのアクセス拡大などに起因しています。この時期の主な動向としては、薬剤製剤法の発展、中枢神経系（CNS）疾患に関する研究の増加、ドラッグデリバリー・システムの革新、てんかんや双極性障害の診断ツールの強化、標的治療のためのバイオマーカーの開発などが挙げられます。

神経疾患の有病率の増加は、今後のジバルプロエクスナトリウム市場の成長を牽引すると予想されます。神経疾患とは、脳、脊髄、神経に影響を及ぼし、筋力低下、発作、認知障害などの機能障害や症状を引き起こす疾患です。平均寿命が延びるにつれて、高齢化社会はアルツハイマー病やパーキンソン病など、人生の後半に発症しやすい疾患の影響を受けやすくなっています。ジバルプロエクスナトリウムは、脳の電気的活動を安定させ、発作を防ぎ、てんかんや双極性障害などによく見られる気分の落ち込みをコントロールすることで、神経疾患の管理に重要な役割を果たしています。例えば、2024年5月に米国疾病予防管理センター（CDC）が発表したデータによると、2021年と2022年に18歳以上の米国成人約290万人が活動性てんかんに罹患しており、米国の成人人口の約1％を占めていることが明らかになっています。神経疾患の有病率が上昇するにつれて、ジバルプロエクスナトリウムの需要は拡大すると予想されます。

ジバルプロエクスナトリウム市場の主なプレーヤーは、患者のコンプライアンスを向上させるために、徐放錠などの革新的なソリューションの開発に注力しています。これらの錠剤は、有効成分を時間をかけて徐々に放出するように設計されているため、投与回数が少なく、より安定した治療効果が期待できます。例えば、2022年3月、インドの製薬会社ユニケム・ラボラトリーズは、250mgと500mgのジバルプロエクスナトリウム徐放錠のジェネリック医薬品について、米国食品医薬品局（FDA）から承認を取得しました。これらの錠剤は、双極性障害に伴う急性の躁病エピソードや混合エピソードの治療薬として、単独治療や他の治療薬との併用、また片頭痛の予防に使用されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のジバルプロエクスナトリウムPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のジバルプロエクスナトリウム市場：成長率分析
• 世界のジバルプロエクスナトリウム市場の実績：規模と成長、2019年～2024年
• 世界のジバルプロエクスナトリウム市場の予測：規模と成長、2024年～2029年 、2034年
• 世界のジバルプロエクスナトリウム総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のジバルプロエクスナトリウム市場：製品タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• タブレット
• カプセル
• 徐放錠
• その他の製品
• 世界のジバルプロエクスナトリウム市場：投与経路別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 経口
• 静脈内
• 世界のジバルプロエクスナトリウム市場：用途別、実績と予測、2019年～2024年、2024年～2029年、2034年
• てんかん治療
• 双極性障害の管理
• 片頭痛予防
• 神経精神疾患
• その他の用途
• 世界のジバルプロエクスナトリウム市場：流通チャネル別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• その他のディストリビューション
• 世界のジバルプロエクスナトリウム市場、錠剤の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 250mg錠
• 500mg錠
• その他の強度タブレット
• 世界のジバルプロエクスナトリウム市場、カプセルの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 125mgカプセル
• 250mgカプセル
• 500mgカプセル
• その他の強度カプセル
• 世界のジバルプロエクスナトリウム市場、徐放錠の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 250mg徐放錠
• 500mg徐放錠
• その他の強度徐放錠
• 世界のジバルプロエクスナトリウム市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 経口溶液
• 注射剤

第7章 地域別・国別分析

• 世界のジバルプロエクスナトリウム市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界のジバルプロエクスナトリウム市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ジバルプロエクスナトリウム市場：競合情勢
• ジバルプロエクスナトリウム市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bausch Health Companies Inc.
• Aurobindo Pharma Limited
• Hikma Pharmaceuticals Public Limited Company
• Amneal Pharmaceuticals Inc.
• Lupin Limited
• Zydus Lifesciences Limited
• Alkem Laboratories Limited
• Alembic Pharmaceuticals Limited
• Supernus Pharmaceuticals Inc.
• Strides Pharma Science Limited
• Upsher-Smith Laboratories LLC
• Ajanta Pharma Limited
• Ishita Active Pharmaceutical Ingredients
• Varahi International
• Roaq Chemicals Private Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ジバルプロエクスナトリウム市場2029年：新たな機会を提供する国
• ジバルプロエクスナトリウム市場2029年：新たな機会を提供するセグメント
• ジバルプロエクスナトリウム市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Divalproex sodium is a prescribed drug used to treat various neurological and psychiatric conditions. It is a combination of sodium valproate and valproic acid, which function by boosting the levels of gamma-aminobutyric acid (GABA) in the brain. GABA is a chemical that helps decrease excessive nerve activity. By stabilizing the brain's electrical signals, this medication promotes mental and neurological equilibrium.

Divalproex sodium is available in several forms, including tablets, capsules, extended-release tablets, and more. Tablets are solid oral dosage forms that contain the active ingredients, pressed into a specific shape for easy administration. It can be taken orally or intravenously and is used to treat conditions including epilepsy, bipolar disorder, migraine prevention, and neuropsychiatric disorders. The drug is available through hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels.

The divalproex sodium market research report is one of a series of new reports from The Business Research Company that provides divalproex sodium market statistics, including divalproex sodium industry global market size, regional shares, competitors with a divalproex sodium market share, divalproex sodium market segments, market trends and opportunities, and any further data you may need to thrive in the divalproex sodium. This divalproex sodium market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The divalproex sodium market size has grown strongly in recent years. It will grow from $1.83 billion in 2024 to $1.97 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth observed during the historical period can be credited to several factors, including increased healthcare spending, the expansion of pharmaceutical distribution networks, a rising demand for outpatient and home-based treatments, government reimbursement and insurance assistance, and a growing need for chronic disease management.

The divalproex sodium market size is expected to see strong growth in the next few years. It will grow to $2.60 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth anticipated during the forecast period can be attributed to the rising prevalence of epilepsy, the increasing incidence of bipolar disorder, higher diagnosis rates of migraine disorders, a growing elderly population susceptible to neurological conditions, and expanded access to healthcare. Key trends in this period include advancements in drug formulation methods, increased research on central nervous system (CNS) disorders, innovations in drug delivery systems, enhanced diagnostic tools for epilepsy and bipolar disorders, and the development of biomarkers for targeted treatments.

The increasing prevalence of neurological disorders is expected to drive the growth of the divalproex sodium market in the future. Neurological disorders are conditions that affect the brain, spinal cord, or nerves, leading to impairments in function and symptoms such as muscle weakness, seizures, or cognitive difficulties. As life expectancy rises, the aging population becomes more susceptible to conditions including Alzheimer's and Parkinson's, which tend to develop later in life. Divalproex sodium plays a crucial role in managing neurological disorders by stabilizing electrical activity in the brain, preventing seizures, and controlling mood swings, which are common in conditions including epilepsy and bipolar disorder. For example, data from the Centers for Disease Control and Prevention (CDC) in May 2024 revealed that approximately 2.9 million U.S. adults aged 18 and older had active epilepsy in 2021 and 2022, accounting for about 1% of the adult population in the U.S. As the prevalence of neurological disorders rises, the demand for divalproex sodium is expected to grow.

Key players in the divalproex sodium market are concentrating on developing innovative solutions, such as extended-release tablets, to improve patient compliance. These tablets are designed to release their active ingredient gradually over time, enabling less frequent dosing and providing more consistent therapeutic effects. For example, in March 2022, Unichem Laboratories, a pharmaceutical company based in India, received approval from the U.S. Food and Drug Administration (FDA) for its generic version of Divalproex Sodium extended-release tablets in 250 mg and 500 mg dosages. These tablets are used to treat acute manic or mixed episodes associated with bipolar disorder, both as a standalone treatment and in combination with other therapies, as well as for preventing migraine headaches.

In June 2024, Lotus Pharmaceuticals, a pharmaceutical company based in Taiwan, acquired the Thailand business and commercial operations of Teva Pharmaceuticals for an undisclosed amount. Following the acquisition, Lotus will assume responsibility for marketing and selling Teva Pharma Thailand's current product portfolio, which will become a wholly owned subsidiary of Teva. This acquisition will allow Lotus to expand its presence in Thailand by adding respiratory and ophthalmic products to its offerings and growing its local workforce to approximately 100 employees. The move will enhance Lotus's ability to reach more hospitals and pharmacies in the region. Teva Pharmaceuticals is an Israel-based manufacturer of divalproex sodium.

Major players in the divalproex sodium market are AbbVie Inc., Sanofi S.A., Abbott Laboratories, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Aurobindo Pharma Limited, Hikma Pharmaceuticals Public Limited Company, Amneal Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Limited, Alembic Pharmaceuticals Limited, Supernus Pharmaceuticals Inc., Strides Pharma Science Limited, Upsher-Smith Laboratories LLC, Ajanta Pharma Limited, Ishita Active Pharmaceutical Ingredients, Varahi International, Roaq Chemicals Private Limited, and MSN Laboratories Private Limited.

North America was the largest region in the divalproex sodium market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in divalproex sodium report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the divalproex sodium market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The divalproex sodium market consists of sales of valproic acid oral solution, carbamazepine tablets, and lamotrigine tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Divalproex Sodium Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on divalproex sodium market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for divalproex sodium ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The divalproex sodium market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Tablets; Capsules; Extended-Release Tablets; Others Products
• 2) By Route of Administration: Oral; Intravenous
• 3) By Application: Epilepsy Treatment; Bipolar Disorder Management; Migraine Prophylaxis; Neuropsychiatric Disorders; Other Applications
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distributions
• Subsegments:
• 1) By Tablets: 250 Mg Tablets; 500 Mg Tablets; Other Strength Tablets
• 2) By Capsules: 125 Mg Capsules; 250 Mg Capsules; 500 Mg Capsules; Other Strength Capsules
• 3) By Extended-Release Tablets: 250 Mg Extended-Release Tablets; 500 Mg Extended-Release Tablets; Other Strength Extended-Release Tablets
• 4) By Other Products: Oral Solution; Injectable Form
• Companies Mentioned: AbbVie Inc.; Sanofi S.A.; Abbott Laboratories; Teva Pharmaceutical Industries Ltd.; Mylan N.V.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Divalproex Sodium Market Characteristics

3. Divalproex Sodium Market Trends And Strategies

4. Divalproex Sodium Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Divalproex Sodium Growth Analysis And Strategic Analysis Framework

• 5.1. Global Divalproex Sodium PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Divalproex Sodium Market Growth Rate Analysis
• 5.4. Global Divalproex Sodium Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Divalproex Sodium Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Divalproex Sodium Total Addressable Market (TAM)

6. Divalproex Sodium Market Segmentation

• 6.1. Global Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Extended-Release Tablets
• Others Products
• 6.2. Global Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• 6.3. Global Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epilepsy Treatment
• Bipolar Disorder Management
• Migraine Prophylaxis
• Neuropsychiatric Disorders
• Other Applications
• 6.4. Global Divalproex Sodium Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distributions
• 6.5. Global Divalproex Sodium Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 250 Mg Tablets
• 500 Mg Tablets
• Other Strength Tablets
• 6.6. Global Divalproex Sodium Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 125 Mg Capsules
• 250 Mg Capsules
• 500 Mg Capsules
• Other Strength Capsules
• 6.7. Global Divalproex Sodium Market, Sub-Segmentation Of Extended-Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 250 Mg Extended-Release Tablets
• 500 Mg Extended-Release Tablets
• Other Strength Extended-Release Tablets
• 6.8. Global Divalproex Sodium Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Solution
• Injectable Form

7. Divalproex Sodium Market Regional And Country Analysis

• 7.1. Global Divalproex Sodium Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Divalproex Sodium Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Divalproex Sodium Market

• 8.1. Asia-Pacific Divalproex Sodium Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Divalproex Sodium Market

• 9.1. China Divalproex Sodium Market Overview
• 9.2. China Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Divalproex Sodium Market

• 10.1. India Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Divalproex Sodium Market

• 11.1. Japan Divalproex Sodium Market Overview
• 11.2. Japan Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Divalproex Sodium Market

• 12.1. Australia Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Divalproex Sodium Market

• 13.1. Indonesia Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Divalproex Sodium Market

• 14.1. South Korea Divalproex Sodium Market Overview
• 14.2. South Korea Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Divalproex Sodium Market

• 15.1. Western Europe Divalproex Sodium Market Overview
• 15.2. Western Europe Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Divalproex Sodium Market

• 16.1. UK Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Divalproex Sodium Market

• 17.1. Germany Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Divalproex Sodium Market

• 18.1. France Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Divalproex Sodium Market

• 19.1. Italy Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Divalproex Sodium Market

• 20.1. Spain Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Divalproex Sodium Market

• 21.1. Eastern Europe Divalproex Sodium Market Overview
• 21.2. Eastern Europe Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Divalproex Sodium Market

• 22.1. Russia Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Divalproex Sodium Market

• 23.1. North America Divalproex Sodium Market Overview
• 23.2. North America Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Divalproex Sodium Market

• 24.1. USA Divalproex Sodium Market Overview
• 24.2. USA Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Divalproex Sodium Market

• 25.1. Canada Divalproex Sodium Market Overview
• 25.2. Canada Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Divalproex Sodium Market

• 26.1. South America Divalproex Sodium Market Overview
• 26.2. South America Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Divalproex Sodium Market

• 27.1. Brazil Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Divalproex Sodium Market

• 28.1. Middle East Divalproex Sodium Market Overview
• 28.2. Middle East Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Divalproex Sodium Market

• 29.1. Africa Divalproex Sodium Market Overview
• 29.2. Africa Divalproex Sodium Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Divalproex Sodium Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Divalproex Sodium Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Divalproex Sodium Market Competitive Landscape And Company Profiles

• 30.1. Divalproex Sodium Market Competitive Landscape
• 30.2. Divalproex Sodium Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Divalproex Sodium Market Other Major And Innovative Companies

• 31.1. Bausch Health Companies Inc.
• 31.2. Aurobindo Pharma Limited
• 31.3. Hikma Pharmaceuticals Public Limited Company
• 31.4. Amneal Pharmaceuticals Inc.
• 31.5. Lupin Limited
• 31.6. Zydus Lifesciences Limited
• 31.7. Alkem Laboratories Limited
• 31.8. Alembic Pharmaceuticals Limited
• 31.9. Supernus Pharmaceuticals Inc.
• 31.10. Strides Pharma Science Limited
• 31.11. Upsher-Smith Laboratories LLC
• 31.12. Ajanta Pharma Limited
• 31.13. Ishita Active Pharmaceutical Ingredients
• 31.14. Varahi International
• 31.15. Roaq Chemicals Private Limited

32. Global Divalproex Sodium Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Divalproex Sodium Market

34. Recent Developments In The Divalproex Sodium Market

35. Divalproex Sodium Market High Potential Countries, Segments and Strategies

• 35.1 Divalproex Sodium Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Divalproex Sodium Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Divalproex Sodium Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer